SCHEDULE 13G
CUSIP NO. 927638403 PAGE 1 OF 16 PAGES
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(AMENDMENT NO. )*
--
Viragen, Inc.
(Name of Issuer)
Common Stock, $.01 par value
(Title of Class of Securities)
927638403
(CUSIP Number)
September 15,2005
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule
is filed:
[ ] Rule 13d-1(b)
[X] Rule 13d-1(c)
[ ] Rule 13d-1(d)
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
SCHEDULE 13G
CUSIP NO. 927638403 PAGE 2 OF 16 PAGES
- ------------------------------------------------------------------------- -
1 NAME OF REPORTING PERSON
I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY)
Omicron Master Trust
- ------------------------------------------------------------------------- -
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (A)[ ]
(B)[ ]
- ------------------------------------------------------------------------- -
3 SEC USE ONLY
- ------------------------------------------------------------------------- -
4 CITIZENSHIP OR PLACE OF ORGANIZATION
Bermuda
- ------------------------------------------------------------------------- -
NUMBER OF 5 SOLE VOTING POWER
SHARES
BENEFICIALLY -0-
OWNED BY ---------------------------------------------------- -
EACH 6 SHARED VOTING POWER
REPORTING
PERSON 2,672,679 shares of Common Stock (See Item 4(a))
WITH: ---------------------------------------------------- -
7 SOLE DISPOSITIVE POWER
-0-
---------------------------------------------------- -
8 SHARED DISPOSITIVE POWER
2,672,679 shares of Common Stock (See Item 4(a))
- ------------------------------------------------------------------------- -
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,672,679 shares of Common Stock (See Item 4(a))
- ------------------------------------------------------------------------- -
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
CERTAIN SHARES (SEE INSTRUCTIONS) [ ]
- ------------------------------------------------------------------------- -
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
6.7% (See Item 4(a))
- ------------------------------------------------------------------------- -
12 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
PN
- ------------------------------------------------------------------------- -
SCHEDULE 13G
CUSIP NO. 927638403 PAGE 3 OF 16 PAGES
- ------------------------------------------------------------------------- -
1 NAME OF REPORTING PERSON
I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY)
Omicron Capital, L.P.
52-2057093
- ------------------------------------------------------------------------- -
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (A)[ ]
(B)[ ]
- ------------------------------------------------------------------------- -
3 SEC USE ONLY
- ------------------------------------------------------------------------- -
4 CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
- ------------------------------------------------------------------------- -
NUMBER OF 5 SOLE VOTING POWER
SHARES
BENEFICIALLY -0-
OWNED BY ---------------------------------------------------- -
EACH 6 SHARED VOTING POWER
REPORTING
PERSON -0-
WITH: ---------------------------------------------------- -
7 SOLE DISPOSITIVE POWER
-0-
---------------------------------------------------- -
8 SHARED DISPOSITIVE POWER
2,672,679 shares of Common Stock (See Item 4(a))
- ------------------------------------------------------------------------- -
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,672,679 shares of Common Stock (See Item 4(a))
- ------------------------------------------------------------------------- -
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
CERTAIN SHARES (SEE INSTRUCTIONS) [ ]
- ------------------------------------------------------------------------- -
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
6.7% (See Item 4(a))
- ------------------------------------------------------------------------- -
12 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
PN
- ------------------------------------------------------------------------- -
SCHEDULE 13G
CUSIP NO. 927638403 PAGE 4 OF 16 PAGES
- ------------------------------------------------------------------------- -
1 NAME OF REPORTING PERSON
I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY)
Omicron Capital, Inc.
52-2032702
- ------------------------------------------------------------------------- -
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (A)[ ]
(B)[ ]
- ------------------------------------------------------------------------- -
3 SEC USE ONLY
- ------------------------------------------------------------------------- -
4 CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
- ------------------------------------------------------------------------- -
NUMBER OF 5 SOLE VOTING POWER
SHARES
BENEFICIALLY -0-
OWNED BY ---------------------------------------------------- -
EACH 6 SHARED VOTING POWER
REPORTING
PERSON -0-
WITH: ---------------------------------------------------- -
7 SOLE DISPOSITIVE POWER
-0-
---------------------------------------------------- -
8 SHARED DISPOSITIVE POWER
2,672,679 shares of Common Stock (See Item 4(a))
- ------------------------------------------------------------------------- -
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,672,679 shares of Common Stock (See Item 4(a))
- ------------------------------------------------------------------------- -
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
CERTAIN SHARES (SEE INSTRUCTIONS) [ ]
- ------------------------------------------------------------------------- -
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
6.7% (See Item 4(a))
- ------------------------------------------------------------------------- -
12 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
CO
- ------------------------------------------------------------------------- -
SCHEDULE 13G
CUSIP NO. 927638403 PAGE 5 OF 16 PAGES
- ------------------------------------------------------------------------- -
1 NAME OF REPORTING PERSON
I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY)
Bruce Bernstein
- ------------------------------------------------------------------------- -
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (A)[ ]
(B)[ ]
- ------------------------------------------------------------------------- -
3 SEC USE ONLY
- ------------------------------------------------------------------------- -
4 CITIZENSHIP OR PLACE OF ORGANIZATION
United States of America
- ------------------------------------------------------------------------- -
NUMBER OF 5 SOLE VOTING POWER
SHARES
BENEFICIALLY -0-
OWNED BY ---------------------------------------------------- -
EACH 6 SHARED VOTING POWER
REPORTING
PERSON -0-
WITH: ---------------------------------------------------- -
7 SOLE DISPOSITIVE POWER
-0-
---------------------------------------------------- -
8 SHARED DISPOSITIVE POWER
2,672,679 shares of Common Stock (See Item 4(a))
- ------------------------------------------------------------------------- -
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,672,679 shares of Common Stock (See Item 4(a))
- ------------------------------------------------------------------------- -
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
CERTAIN SHARES (SEE INSTRUCTIONS) [ ]
- ------------------------------------------------------------------------- -
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
6.7% (See Item 4(a))
- ------------------------------------------------------------------------- -
12 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
IN
- ------------------------------------------------------------------------- -
SCHEDULE 13G
CUSIP NO. 927638403 PAGE 6 OF 16 PAGES
- ------------------------------------------------------------------------- -
1 NAME OF REPORTING PERSON
I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY)
Olivier Morali
- ------------------------------------------------------------------------- -
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (A)[ ]
(B)[ ]
- ------------------------------------------------------------------------- -
3 SEC USE ONLY
- ------------------------------------------------------------------------- -
4 CITIZENSHIP OR PLACE OF ORGANIZATION
France
- ------------------------------------------------------------------------- -
NUMBER OF 5 SOLE VOTING POWER
SHARES
BENEFICIALLY -0-
OWNED BY ---------------------------------------------------- -
EACH 6 SHARED VOTING POWER
REPORTING
PERSON -0-
WITH: ---------------------------------------------------- -
7 SOLE DISPOSITIVE POWER
-0-
---------------------------------------------------- -
8 SHARED DISPOSITIVE POWER
2,672,679 shares of Common Stock (See Item 4(a))
- ------------------------------------------------------------------------- -
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,672,679 shares of Common Stock (See Item 4(a))
- ------------------------------------------------------------------------- -
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
CERTAIN SHARES (SEE INSTRUCTIONS) [ ]
- ------------------------------------------------------------------------- -
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
6.7% (See Item 4(a))
- ------------------------------------------------------------------------- -
12 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
IN
- ------------------------------------------------------------------------- -
SCHEDULE 13G
CUSIP NO. 927638403 PAGE 7 OF 16 PAGES
- ------------------------------------------------------------------------- -
1 NAME OF REPORTING PERSON
I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY)
Winchester Global Trust Company Limited
- ------------------------------------------------------------------------- -
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (A)[ ]
(B)[ ]
- ------------------------------------------------------------------------- -
3 SEC USE ONLY
- ------------------------------------------------------------------------- -
4 CITIZENSHIP OR PLACE OF ORGANIZATION
Bermuda
- ------------------------------------------------------------------------- -
NUMBER OF 5 SOLE VOTING POWER
SHARES
BENEFICIALLY -0-
OWNED BY ---------------------------------------------------- -
EACH 6 SHARED VOTING POWER
REPORTING
PERSON 2,672,679 shares of Common Stock (See Item 4(a))
WITH: ---------------------------------------------------- -
7 SOLE DISPOSITIVE POWER
-0-
---------------------------------------------------- -
8 SHARED DISPOSITIVE POWER
2,672,679 shares of Common Stock (See Item 4(a))
- ------------------------------------------------------------------------- -
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,672,679 shares of Common Stock (See Item 4(a))
- ------------------------------------------------------------------------- -
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
CERTAIN SHARES (SEE INSTRUCTIONS) [ ]
- ------------------------------------------------------------------------- -
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
6.7% (See Item 4(a))
- ------------------------------------------------------------------------- -
12 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
CO
- ------------------------------------------------------------------------- -
SCHEDULE 13G
CUSIP NO. 927638403 PAGE 8 OF 16 PAGES
- ------------------------------------------------------------------------- -
1 NAME OF REPORTING PERSON
I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY)
Oskar P. Lewnowski
- ------------------------------------------------------------------------- -
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (A)[ ]
(B)[ ]
- ------------------------------------------------------------------------- -
3 SEC USE ONLY
- ------------------------------------------------------------------------- -
4 CITIZENSHIP OR PLACE OF ORGANIZATION
Austria
- ------------------------------------------------------------------------- -
NUMBER OF 5 SOLE VOTING POWER
SHARES
BENEFICIALLY -0-
OWNED BY ---------------------------------------------------- -
EACH 6 SHARED VOTING POWER
REPORTING
PERSON 2,672,679 shares of Common Stock (See Item 4(a))
WITH: ---------------------------------------------------- -
7 SOLE DISPOSITIVE POWER
-0-
---------------------------------------------------- -
8 SHARED DISPOSITIVE POWER
2,672,679 shares of Common Stock (See Item 4(a))
- ------------------------------------------------------------------------- -
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,672,679 shares of Common Stock (See Item 4(a))
- ------------------------------------------------------------------------- -
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
CERTAIN SHARES (SEE INSTRUCTIONS) [ ]
- ------------------------------------------------------------------------- -
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
6.7% (See Item 4(a))
- ------------------------------------------------------------------------- -
12 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
IN
- ------------------------------------------------------------------------- -
SCHEDULE 13G
CUSIP NO. 927638403 PAGE 9 OF 16 PAGES
Item 1(a). Name of Issuer:
Viragen, Inc. (the "Issuer")
Item 1(b). Address of Issuer's Principal Executive Offices:
865 SW 78th Avenue
Suite 100
Plantation, Florida 33324
Item 2(a). Names of Persons Filing:
Omicron Master Trust ("Omicron Trust")
Omicron Capital, L.P. ("Omicron Capital")
Omicron Capital, Inc. ("OCI")
Bruce Bernstein ("Bernstein")
Olivier Morali ("Morali")
Winchester Global Trust Company Limited ("WGTCL")
Oskar P. Lewnowski ("Lewnowski")
Item 2(b). Address of Principal Business Office:
Omicron Trust - c/o Olympia Capital International Inc.,
Williams House, 20 Reid Street, Hamilton HM11, Bermuda
Omicron Capital - 650 Fifth Avenue, 24th Floor, New York,
New York 10019
OCI - 650 Fifth Avenue, 24th Floor, New York, New York 10019
Bernstein - 650 Fifth Avenue, 24th Floor, New York, New York
10019
Morali - 650 Fifth Avenue, 24th Floor, New York, New York
10019
WGTCL - c/o Winchester Fiduciary Limited, Williams House,
20 Reid Street, Hamilton HM11, Bermuda
Lewnowski - c/o Winchester Fiduciary Limited, Williams House,
20 Reid Street, Hamilton HM11, Bermuda
Item 2(c). Place of Organization or Citizenship:
Omicron Trust - Bermuda
Omicron Capital - Delaware
OCI - Delaware
Bernstein - United States of America
Morali - France
WGTCL - Bermuda
Lewnowski - Austria
Item 2(d). Title of Class of Securities:
Common Stock, $.01 par value per share of the Issuer (the
"Common Stock")
Item 2(e). CUSIP Number:
927638403
Item 3. This Schedule is filed pursuant to Rule 13d-1(c) by Omicron
Trust, Omicron Capital, OCI, Bernstein, Morali, WGTCL and
Lewnowski.
Item 4. Ownership:
(a) Amount Beneficially Owned:
SCHEDULE 13G
CUSIP NO. 927638403 PAGE 10 OF 16 PAGES
Omicron Trust: 2,672,679 shares*
Omicron Capital: 2,672,679 shares*
OCI: 2,672,679 shares*
Morali: 2,672,679 shares*
Bernstein: 2,672,679 shares
WGTCL: 2,672,679 shares*
Lewnowksi: 2,672,679 shares*
(b) Percent of Class:
Omicron Trust: 6.7%
Omicron Capital: 6.7%
OCI: 6.7%
Bernstein: 6.7%
Morali: 6.7%
WGTCL: 6.7%
Lewnowski: 6.7%
(Based on 37,087,677 shares of Common Stock outstanding
as of September 6, 2005, as stated in the Issuer's
Annual Report on Form 10-K for the year ended June 30,
2005.)
(c) Number of Shares as to which the Person has:
Omicron Trust, WGTCL and Lewnowski:
----------------------------------
(i) sole power to vote or to direct
the vote
-0-
(ii) shared power to vote or to direct the vote:
2,672,679 shares of Common Stock*
(iii) sole power to dispose or to direct the
disposition of
-0-
(iv) shared power to dispose or to direct the
disposition of
2,672,679 shares of Common Stock*
Omicron Capital, OCI, Bernstein and Morali:
------------------------------------------
(i) sole power to vote or to direct
the vote
-0-
(ii) shared power to vote or to direct the vote:
-0-
(iii) sole power to dispose or to direct the
disposition of
-0-
SCHEDULE 13G
CUSIP NO. 927638403 PAGE 11 OF 16 PAGES
(iv) shared power to dispose or to direct the
disposition of
2,672,679 shares of Common Stock*
*Omicron Capital serves as investment manager to Omicron Trust. By reason of
such relationship, Omicron Capital may be deemed to share dispositive power over
the shares of Common Stock owned by Omicron Trust. Omicron Capital disclaims
beneficial ownership of the shares of Common Stock listed as beneficially owned
by Omicron Trust or any other person reporting on this Schedule.
OCI serves as general partner of Omicron Capital. By reason of such
relationship, OCI may be deemed to share dispositive power over the shares of
Common Stock listed as beneficially owned by Omicron Capital. OCI disclaims
beneficial ownership of the shares of Common Stock listed as beneficially owned
by Omicron Capital or any other person reporting on this Schedule.
Morali serves as president and a director and is a stockholder of OCI. By reason
of such relationships, Morali may be deemed to share dispositive power over the
shares of Common Stock listed as beneficially owned by OCI. Morali disclaims
beneficial ownership of the shares of Common Stock listed as beneficially owned
by OCI or any other person reporting on this Schedule.
Bernstein serves as chief executive officer of OCI and is a stockholder of OCI.
By reason of such relationships, Bernstein may be deemed to share dispositive
power over the shares of Common Stock listed as beneficially owned by OCI.
Bernstein disclaims beneficial ownership of the shares of Common Stock listed as
beneficially owned by OCI or any other person reporting on this Schedule.
WGTCL serves as trustee of Omicron Trust. By reason of such relationship, WGTCL
may be deemed to shares voting and dispositive power over the shares of Common
Stock listed as beneficially owned by Omicron Trust. WGTCL disclaims beneficial
ownership of the shares of Common Stock listed as beneficially owned by Omicron
Trust or any other person reporting on this Schedule.
WGTCL may be deemed to be controlled by Lewnowski. By reason of such control,
Lewnowski may be deemed to share voting and dispositive power over the shares of
Common Stock listed as beneficially owned by WGTCL. Lewnowski disclaims
beneficial ownership of the shares of Common Stock listed as beneficially owned
by WGTCL.
The shares of Common Stock reported as beneficially owned are shares that
Omicron Trust has the right to acquire upon conversion of the Issuer's 7%
Convertible Notes due 2008 held by Omicron Trust (the "Note") and upon exercise
of the Issuer's Common Stock Purchase Warrant held by Omicron Trust (the
"Warrant"). Omicron Capital, OCI, Bernstein, Morali, WGTCL and Lewnowski each
disclaims beneficial ownership of such shares of Common Stock.
Of the shares of Common Stock reported as beneficially owned, 1,904,762 are
shares of Common Stock which Omicron Trust has the right to acquire upon
conversion of the Note. Of the shares of Common Stock reported as beneficially
owned, 767,917 shares of Common Stock are shares which Omicron Trust has the
right to acquire upon exercise of the Warrant.
Item 5. Ownership of Five Percent or Less of a Class:
Not applicable
Item 6. Ownership of More Than Five Percent on Behalf of Another
Person:
Not applicable
SCHEDULE 13G
CUSIP NO. 927638403 PAGE 12 OF 16 PAGES
Item 7. Identification and Classification of the Subsidiary which
Acquired the Security Being Reported on by the Parent
Holding Company:
Not applicable
Item 8. Identification and Classification of Members of the Group:
Not applicable
Item 9. Notice of Dissolution of Group:
Not applicable
Item 10. Certification:
By signing below I certify that, to the best of its knowledge and belief, the
securities referred to above were not acquired and are not held for the purpose
of or with the effect of changing or influencing the control of the issuer of
the securities and were not acquired and are not held in connection with or as a
participant in any transaction having that purpose or effect.
Exhibits:
Exhibit I: Joint Filing Agreement, dated as of October 6, 2005, by and
among Omicron Trust, Omicron Capital, OCI, Bernstein, Morali, WGTCL and
Lewnowski.
SCHEDULE 13G
CUSIP NO. 927638403 PAGE 13 OF 16 PAGES
SIGNATURE
By signing below each signatory certifies that, to the best of its
knowledge and belief, the securities referred to above were not acquired and are
not held for the purpose of or with the effect of changing or influencing the
control of the issuer of the securities and were not acquired and are not held
in connection with or as a participant in any transaction having that purpose or
effect.
Date: October 6, 2005
OMICRON MASTER TRUST
By: OMICRON CAPITAL, L.P.,
Investment Manager
By: OMICRON CAPITAL, INC.,
General Partner
By: /s/ Olivier H. Morali
----------------------------
Olivier H. Morali
Title: President
OMICRON CAPITAL, L.P.
By: OMICRON CAPITAL, INC.,
General Partner
By: /s/ Olivier H. Morali
----------------------------
Olivier H. Morali
Title: President
OMICRON CAPITAL, INC.
By: /s/ Olivier H. Morali
----------------------------
Olivier H. Morali
Title: President
/s/ Bruce Bernstein
----------------------------
Bruce Bernstein
/s/ Olivier H. Morali
----------------------------
Olivier H. Morali
SCHEDULE 13G
CUSIP NO. 927638403 PAGE 14 OF 16 PAGES
WINCHESTER GLOBAL TRUST COMPANY LIMITED
By: /s/ Oskar P. Lewnowksi
----------------------------
Oskar P. Lewnowski
Title: Chairman
/s/ Oskar P. Lewnowksi
----------------------------
Oskar P. Lewnowski